Multicenter study on the diagnostic value of a new RIA for the detection of free plasma metanephrines in the work-up for pheochromocytoma

Annals of the New York Academy of Sciences

Volumn 1073, Issue , 2006, Pages 358-373

  Lenz, Tomas ^a,f,g   Zorner, Joachim ^a   Kirchmaier, Carl ^b   Pillitteri, Daniele ^b   Badenhoop, Klaus ^c   Bartel, Christine ^c   Geiger, Helmut ^c   Hasselbacher, Katrin ^d   Tuschy, Ulrich ^d   Westermann, Jürgen ^e   Salewski, Lothar ^e  

^a Kuratorium für Dialyse und Nierentransplantation e V KfH Kidney Center   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d HELIOS KLINIKUM ERFURT   (Germany)

^e IBL GmbH   (Germany)

^f Institute for the Prevention of Kidney Diseases and Hypertension (IPNH)   (Germany)

^g Institute for the Prevention of Kidney Diseases and Hypertension ^*  (Germany)

Author keywords

EDTA; Free plasma metanep; Heparin; Hrines; Immunoassay; LC MS MS; Pheochromocytoma

Indexed keywords

EDETIC ACID; HEPARIN; METADRENALIN;

ADULT; AGED; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PHEOCHROMOCYTOMA; TANDEM MASS SPECTROMETRY;

EID: 33745831003     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1353.040     Document Type: Conference Paper

References (20)

1. ROSANO, T.G. et al. 1991. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin. Chem. 37: 1854-1867.
2. SUTTON, J. et al. 1981. Prevalence of clinically unsuspected pheochromocytoma. Review of 50-year autopsy series. Mayo Clin. Proc. 56: 354-360.
3. PLATTS, J. et al. 1995. Death from pheochromocytoma: lessons from a post mortem survey. J. R. Coll. Physicians Lond. 29: 299-306.
4. LO, C. et al. 2000. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am. J. Surg. 179: 212-215.
5. POMARES, F. et al. 1998. Differences between sporadic and multiple endocrine neo-plasia type 2A pheochromocytoma. Clin. Endocrinol. 48: 195-200.
6. GRAHAM, P. et al. 1993. Laboratory diagnosis of pheochromocytoma: which analytes should we measure? Ann. Clin. Biochem. 30: 129-134.
7. LUCON, A. et al. 1997. Pheochromocytoma: study of 50 cases. J. Urol. 157: 1208-1212.
8. MANELLI, M. et al. 1999. Pheochromocytoma in Italy: a multicentric retrospective study. Eur. J. Endocrinol. 141: 619-624.
9. GERLO, E. & C. SEVENS. 1994. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases. Clin. Chem. 40: 250-256.
10. RABER, W. et al. 2000. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch. Intern. Med. 160: 2957-2963.
11. GROUZMANN, E. et al. 2001. Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma. Clin. Chem. 47: 1075-1082.
12. WESTERMANN, J. et al. 2002. Simple, rapid and sensitive determination of epinephrine and norepinephrine in urine and plasma by non-competitive enzyme immunoassay, compared with HPLC method. Clin. Lab. 48: 61-71.
13. TILGMANN, C. & N. KALKKINEN. 1990. Purification and partial characterization of rat liver soluble catechol-o-methyltransferase. FEBS Lett. 264: 95-99.
14. DAVIES, C. 1994. Technical performance concepts. In The Immunoassay Handbook. D. Wild, Ed.: 83-100. Stockton Press. New York.
15. NIX, B. 1994. Calibration curve-fitting. In The Immunoassay Handbook. D. Wild, Ed.: 117-123. Stockton Press. New York.
16. PASSING, W. & H. BABLOK. 1983. A new procedure for testing the equality of measurements from two methods. J. Clin. Chem. Clin. Biochem. 21: 709-720.
17. WASSELL, J. et al. 1999. Freedom from drug interference in new immunoassays for urinary catecholamines and metanephrines. Clin. Chem. 45: 2216-2223.
18. BOULOUX, P. & M. FAKEEH. 1995. Investigation of pheochromocytoma. Clin. Endocrinol. 43: 657-664.
19. WEISSMAN, C. et al. 1995. Do synthetic adrenergic agents interfere with the measurement of endogenous plasma catecholamine concentrations? J. Crit. Care 10: 72-77.
20. LENDERS, J.W.M. et al. 2005. Phaeochromocytoma. Lancet 366: 665-675.